Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Ai Pocuscardiac

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Ai Pocuscardiac1
  • Whole Exome Sequencing Wes1

Active Sponsors

  • Nicklaus Children's Hospital f/k/a Miami Children's Hospital1
  • University of California, San Francisco1

Top Investigators

Related Conditions

  • Genitourinary Anomalies1
  • Skeletal Anomalies1
  • Structural Anomalies1
  • Thorax Anomalies1
  • Gastrointestinal Anomalies1

Activity Timeline